Tutti gli studi
ReclutamentoFASE3INTERVENTISTICO

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

This research study is looking at a new medicine called nipocalimab for adults who have a condition called generalised myasthenia gravis, or gMG. gMG causes muscles to become weak and tired easily. The main aim of the study is to find out how well nipocalimab works compared to a 'dummy' medicine (placebo) and whether it is safe to use. The study also includes a smaller part to see how the body handles nipocalimab when it's given as an injection just under the skin, compared to giving it through a drip into a vein. This helps researchers understand the best way to give the medicine. Participants will either receive the active medicine or the placebo, and their health and symptoms will be carefully monitored throughout the study.

A colpo d'occhio

Stato
Reclutamento
Fase
FASE3
Sponsor
Janssen Ricerca & Sviluppo, LLC
Obiettivo di iscrizione
199
Inizio
15 Lug 2021
Completamento stimato
30 Mar 2029

Risultati

Risultati di questo studio

Pubblicato Luglio 2025

I risultati di questo studio sono stati pubblicati.

Risultato principale
Double-blind (DB) Phase: Average Change From Baseline in Myasthenia Gravis - Activities of Daily Living (MG-ADL) Total Score Over Weeks 22, 23, and 24
Average change from baseline over multiple timepoints (Weeks 22, 23, and 24) was reported in this outcome measure. The MG-ADL provided a rapid assessment of the participant's MG symptom severity of eight functions (talking, chewing, swallowing, breathing, impairment of ability to brush teeth or comb hair, impairment of ability to arise from a chair, double vision, eyelid droop) rated on a 4-point scale ranging from 0 (normal) to 3 (severe). MG-ADL total score was sum of 8 individual items, which ranging from 0 to 24. A higher score indicated greater symptom severity. Baseline was defined as the average of the screening and Day 1 total scores.
Risultati completi nel registro

Di cosa tratta questo studio?

This research study is about a muscle weakness condition called generalised myasthenia gravis (gMG). If you have gMG, your body's immune system mistakenly attacks healthy connections between your nerves and muscles, leading to muscle weakness that can affect things like your eyes, face, throat, and limbs. This can make everyday activities quite challenging.

The study is testing a new medicine called nipocalimab. Researchers want to see if this medicine can help improve the symptoms of gMG and make a real difference to people's lives. To do this, they will compare nipocalimab to a 'dummy' treatment (called a placebo), which looks exactly like the real medicine but contains no active ingredients. This comparison helps them understand if any changes are truly due to nipocalimab or might have happened anyway.

Another important part of this study is looking at how nipocalimab works when given in different ways. Some participants will receive the medicine through a drip into a vein, which is a common way to give medicines. Others will receive it as an injection just under the skin. This helps the researchers figure out the most effective and convenient way to deliver the medicine, which could be very helpful for future patients.

Punti chiave

  • This study is testing a new medicine, nipocalimab, for generalised myasthenia gravis (gMG).
  • It aims to see if nipocalimab is safe and effective compared to a dummy treatment (placebo).
  • The medicine might be given through a drip or as an injection under the skin.
  • Participation involves regular clinic visits for treatments, tests, and symptom checks.
  • You will be closely monitored, and your care team will track your health.
  • You can withdraw from the study at any point without affecting your regular medical care.

Chi può essere idoneo?

To join this study, adults must have a confirmed diagnosis of generalised myasthenia gravis (gMG) that affects various muscles in their body, not just a mild form. You would need to be experiencing specific levels of muscle weakness in your daily activities according to a special scale.

The study also has some rules about other health conditions. For example, you can't have certain problems with your immune system or a history of a 'myasthenia crisis' recently. If you've had surgery to remove your thymus gland, there's a time limit for when you can join after that surgery. Also, if you know you're allergic to nipocalimab or its ingredients, you wouldn't be able to take part.

For women who could become pregnant, special pregnancy tests are required, and male participants must agree not to donate sperm during the study and for a period after. If you're considering the part of the study where the medicine is given as an injection under the skin, you'd need suitable skin on your tummy for the injections and be able to keep your regular medications for gMG stable for the first few weeks.

Questo studio potrebbe fare al caso tuo?

Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.

  1. Do I have a confirmed diagnosis of generalised myasthenia gravis (gMG)?
  2. Are my gMG symptoms affecting my daily activities to a certain degree?
  3. Have I had a thymectomy (surgery to remove my thymus gland) more than a year ago?
  4. Do I have any specific immune problems or allergies that might stop me from joining?
  5. Am I willing to attend regular clinic visits and follow the study instructions?
Rispondi a ogni domanda per vedere il tuo risultato.

Cosa comporta la partecipazione?

If you decide to take part in this study, you'll be assigned to either receive the new medicine, nipocalimab, or a placebo (a dummy medicine). You won't know which one you're getting, and neither will your study doctor. Depending on which group you're in, the medicine could be given through a drip into a vein or as an injection under your skin. This will involve regular visits to the study clinic for these treatments and check-ups.

Throughout the study, the research team will closely monitor your health, symptoms, and how you're feeling. This will involve various tests, blood samples, and questionnaires at regular visits. These visits are important for the team to understand how the medicine is working and to make sure you are safe. For some participants, there's a specific part of the study (called a substudy) where you'll receive injections under the skin. This will also involve keeping your current gMG medications, like steroids, at a steady dose for the first 8 weeks.

The total duration of your participation in the study will involve regular visits for treatment and assessments, followed by a period where your health is still monitored even after you stop receiving the study medicine. You will be given a detailed schedule of visits and procedures if you decide to take part, and you will always have the right to withdraw from the study at any time.

Rischi e benefici potenziali

Taking part in a clinical trial has potential benefits and risks. You might benefit from receiving a new medicine that could improve your gMG symptoms, and you'll be closely monitored by a healthcare team. However, nipocalimab is still being tested, which means its full effects and side effects aren't completely known yet. You might experience side effects from the medicine, or it might not work for you. There's also a chance you could receive the placebo, which won't directly treat your gMG but will still involve clinic visits and procedures. As with any study, there's a small risk associated with blood draws and other tests. You have the right to stop taking part in the study at any time, for any reason, without it affecting your usual medical care.

Locations (112)

  • Neuromuscular Research Center and Clinic
    Codice postale verificato
    Paradise Valley, United States· Reclutamento
  • HonorHealth Neurology
    Codice postale verificato
    Scottsdale, Stati Uniti· Completato
  • Università della California Meridionale
    Codice postale verificato
    Los Angeles, Stati Uniti· Completato
  • Stanford University
    Codice postale verificato
    Palo Alto, Stati Uniti· Completato
  • Care Access Research
    Codice postale verificato
    Pasadena, United States· Reclutamento
  • Università del Colorado Campus Medico Anschutz
    Codice postale verificato
    Aurora, Stati Uniti· Reclutamento
  • Yale New Haven Hospital
    Codice postale verificato
    New Haven, Stati Uniti· Reclutamento
  • FM Clinical Research, LLC South Florida Neurology Associates, P. A.
    Codice postale verificato
    Boca Raton, United States· Reclutamento
  • University of Florida Health Jacksonville
    Codice postale verificato
    Jacksonville, Stati Uniti· Completato
  • Medsol Clinical Research Center Inc
    Codice postale verificato
    Port Charlotte, United States· Reclutamento
  • University of South Florida
    Codice postale verificato
    Tampa, Stati Uniti· Reclutamento
  • Augusta University
    Codice postale verificato
    Augusta, United States· Completato

Domande comuni

What is generalised myasthenia gravis (gMG)?

gMG is a condition where your body's immune system mistakenly attacks parts of your muscles, making them weak and tired easily, affecting many parts of your body.

What is nipocalimab?

Nipocalimab is a new medicine being tested to see if it can help improve the symptoms of gMG. It's not yet approved for general use.

Che cos'è un placebo?

A placebo is a 'dummy' treatment that looks like the actual medicine but doesn't contain any active ingredients. It helps researchers fairly compare the new medicine's effects.

Come verrà somministrato il medicinale?

Depending on which group you're in, it could be given through a drip into your vein or as an injection just under your skin.

Posso abbandonare lo studio se cambio idea?

Yes, you can choose to leave the study at any time, for any reason, without it affecting your medical care.

Come saperne di più

Contatto per lo Studio

Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.

Interessato a partecipare?

Registrati per ricevere aggiornamenti

Condividi i tuoi dettagli e il team di ricerca per "A Study of Nipocalimab Administered to Adults With Generaliz…" ti contatterà se potresti essere idoneo. Parla sempre con il tuo medico prima di accettare di partecipare.

Discussione

Discussione della comunità

Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.